<--- Back to Details
First PageDocument Content
Cell biology / Stem cells / T cells / Cell therapy / Bone marrow suppression / Angiogenesis / Stem cell / Acute myeloid leukemia / Regulation S-K / Biology / Medicine / Biotechnology
Date: 2013-12-03 09:47:53
Cell biology
Stem cells
T cells
Cell therapy
Bone marrow suppression
Angiogenesis
Stem cell
Acute myeloid leukemia
Regulation S-K
Biology
Medicine
Biotechnology

Add to Reading List

Source URL: pluristem.com

Download Document from Source Website

File Size: 476,60 KB

Share Document on Facebook

Similar Documents

THE YALE LAW JOURNAL FORUM JANUARY 22, 2015 Financial Regulation and Cost-Benefit Analysis Cass R. Sunstein i. w h a t g o v e r n m e n t d o e s n ’t k n o w

DocID: 1sJcC - View Document

July 21, 2016 Mr. Brent J. Fields, Secretary Securities and Exchange Commission 100 F Street, NE Washington, DCRe: File No. S7-06-16, Business and Financial Disclosure Required by Regulation S-K

DocID: 1rBpj - View Document

Response to Concept Release: Business and Financial Disclosure Required by Regulation S-K To whom it may concern, We welcome the opportunity to respond to your consultation (file no. S7on the proposed changes to

DocID: 1rzS4 - View Document

Cargo airlines / Business / Transport / Economy / ABX Air / DHL Express / Wilmington /  Ohio / Regulation S-K / ABX / Airborne Express / Airborne Airpark

® ABX HOLDINGS, INCAnnual Report ABX Holdings 2007 Annual Report

DocID: 1rqcm - View Document

Insurance / SEC filings / Economy / Types of insurance / United States securities law / Reinsurance companies / Auditing / Regulation S-K / Reinsurance Group of America / Forward-looking statement / Financial reinsurance / Financial services

2009 Annual Report   To Our Shareholders:

DocID: 1rlHY - View Document